<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="38607">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02051322</url>
  </required_header>
  <id_info>
    <org_study_id>Trunk</org_study_id>
    <nct_id>NCT02051322</nct_id>
  </id_info>
  <brief_title>Comparison of Lung Administration With Three Different Nebulizer</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cliniques universitaires Saint-Luc- Université Catholique de Louvain</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cliniques universitaires Saint-Luc- Université Catholique de Louvain</source>
  <oversight_info>
    <authority>Belgium: Ethics Committee</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      Comparison between three modalities of nebulization.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2014</start_date>
  <completion_date type="Anticipated">February 2014</completion_date>
  <primary_completion_date type="Anticipated">February 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Lung deposition by urinary measure</measure>
    <time_frame>10 minutes</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">6</enrollment>
  <condition>Healthy Subjects</condition>
  <arm_group>
    <arm_group_label>Jet Nebulizer</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Nebulization with a jet nebulizer and a classic mask</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Trunk Mask Nebulizer</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Nebulization with a je nebulizer and a trunk mask</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Aerobika Nebulizer</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Nebulization with an Aerobika</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Jet Nebulizer</intervention_name>
    <arm_group_label>Jet Nebulizer</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Trunk Mask Nebulizer</intervention_name>
    <arm_group_label>Trunk Mask Nebulizer</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Aerobika Nebulizer</intervention_name>
    <arm_group_label>Aerobika Nebulizer</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy Subjects

        Exclusion Criteria:

          -  Pulmonary disease

          -  Cardiac disease
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Gregory Reychler, PhD</last_name>
    <email>gregory.reychler@uclouvain.be</email>
  </overall_contact>
  <location>
    <facility>
      <name>Cliniques universitaires Saint-Luc</name>
      <address>
        <city>Brussels</city>
        <zip>1200</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gregory Reychler, PhD</last_name>
      <email>gregory.reychler@uclouvain.be</email>
    </contact>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <lastchanged_date>January 30, 2014</lastchanged_date>
  <firstreceived_date>January 29, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
